Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 72 publications
Correction: Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Journal: British journal of cancer
Published: March 04, 2024
Alterations in Pre/Post Oxygenator Flows Due to Fibrin Deposition in the CardioHelp System-A Case Report.
Journal: The journal of extra-corporeal technology
Published: April 13, 2022
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer.
Journal: British journal of cancer
Published: July 05, 2021
A phase 2 evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability.
Journal: Cancer
Published: May 13, 2021
Trastuzumab tolerability in the treatment of advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress HER2/neu.
Journal: Gynecologic oncology
Published: May 02, 2021
Financial toxicity in patients with gynecologic malignancies: a cross sectional study.
Journal: Journal of gynecologic oncology
Published: April 21, 2021
Integrated mutational landscape analysis of uterine leiomyosarcomas.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 20, 2021
DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo.
Journal: Gynecologic oncology
Published: March 31, 2021
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 04, 2021
Novel mesothelin antibody-drug conjugates: current evidence and future role in the treatment of ovarian cancer.
Journal: Expert opinion on biological therapy
Published: December 28, 2020
Prescribed medical cannabis in women with gynecologic malignancies: A single-institution survey-based study.
Journal: Gynecologic oncology reports
Published: September 01, 2020
Last Updated: 09/26/2026